| 3.1 |
9.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.5 |
12.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.9 |
5.7 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.5 |
4.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 1.4 |
5.7 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.2 |
4.8 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 1.1 |
3.3 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 1.1 |
2.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.1 |
3.3 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 1.0 |
3.1 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.0 |
3.0 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.0 |
4.0 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.0 |
3.0 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.0 |
2.9 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.9 |
3.8 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.9 |
2.8 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.9 |
2.7 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.9 |
2.7 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.9 |
2.7 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.8 |
5.0 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.8 |
3.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.8 |
5.0 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.8 |
2.5 |
GO:0021557 |
oculomotor nerve development(GO:0021557) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.8 |
2.5 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.8 |
0.8 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.8 |
4.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.8 |
4.8 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.8 |
2.3 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.7 |
2.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.7 |
0.7 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 |
13.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.7 |
2.2 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.7 |
3.4 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.7 |
2.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.7 |
2.1 |
GO:0046544 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) response to interleukin-15(GO:0070672) |
| 0.7 |
1.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.7 |
2.0 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.7 |
2.6 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.6 |
1.9 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.6 |
1.9 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.6 |
1.9 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.6 |
0.6 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.6 |
1.9 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.6 |
5.5 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.6 |
1.8 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.6 |
3.6 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.6 |
4.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.6 |
2.3 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.6 |
1.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.6 |
2.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.6 |
1.2 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.6 |
1.7 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 |
1.1 |
GO:0042637 |
catagen(GO:0042637) |
| 0.6 |
2.8 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.6 |
2.8 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
2.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.6 |
4.4 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.5 |
4.9 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.5 |
1.6 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.5 |
2.1 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.5 |
2.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 |
4.7 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.5 |
2.6 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.5 |
1.6 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.5 |
0.5 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.5 |
5.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.5 |
2.6 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.5 |
1.6 |
GO:0072554 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel lumenization(GO:0072554) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.5 |
2.6 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.5 |
2.6 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.5 |
1.0 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.5 |
1.5 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.5 |
3.0 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.5 |
7.1 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 |
1.5 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.5 |
1.5 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.5 |
1.5 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.5 |
0.5 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.5 |
1.5 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.5 |
1.5 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.5 |
2.9 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.5 |
4.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.5 |
4.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.5 |
3.7 |
GO:1903961 |
positive regulation of anion transmembrane transport(GO:1903961) |
| 0.5 |
0.9 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.5 |
2.3 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.5 |
2.7 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.5 |
1.4 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.5 |
3.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.4 |
0.4 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.4 |
4.9 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.4 |
1.3 |
GO:2000612 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid hormone generation(GO:2000609) positive regulation of thyroid hormone generation(GO:2000611) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.4 |
1.7 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 |
0.4 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.4 |
0.8 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.4 |
1.3 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.4 |
0.8 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.4 |
3.7 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.4 |
1.2 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.4 |
1.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.4 |
0.8 |
GO:1904395 |
positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
0.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.4 |
3.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.4 |
3.6 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.4 |
2.4 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.4 |
1.2 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.4 |
1.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.4 |
1.6 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.4 |
6.1 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 |
1.9 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) negative regulation of cytolysis(GO:0045918) |
| 0.4 |
1.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.4 |
3.3 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.4 |
5.1 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.4 |
1.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
0.4 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.4 |
1.8 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.4 |
1.4 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.4 |
1.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.4 |
2.2 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 |
1.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 |
1.8 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.4 |
2.5 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.4 |
1.1 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.4 |
1.1 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 0.4 |
1.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
0.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.3 |
1.4 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.3 |
1.7 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
1.0 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.3 |
1.4 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 |
2.4 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.3 |
1.7 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.3 |
3.7 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 |
1.0 |
GO:1903903 |
striated muscle atrophy(GO:0014891) regulation of establishment of T cell polarity(GO:1903903) |
| 0.3 |
1.0 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.3 |
0.6 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.3 |
1.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
0.6 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.3 |
1.3 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.3 |
1.2 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.3 |
0.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.3 |
0.9 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
0.9 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.3 |
1.5 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.3 |
0.9 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.3 |
0.3 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.3 |
0.9 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 |
1.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.3 |
5.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.3 |
1.8 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.3 |
1.5 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.3 |
1.2 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.3 |
4.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 |
1.2 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.3 |
0.6 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.3 |
0.9 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.3 |
1.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
2.3 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.3 |
1.1 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.3 |
1.7 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 |
2.3 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.3 |
0.9 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.3 |
3.4 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.3 |
0.8 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.3 |
0.3 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.3 |
0.8 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.3 |
1.1 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.3 |
1.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
2.4 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.3 |
0.5 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 |
1.9 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.3 |
0.5 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
1.1 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 |
1.1 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.3 |
0.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
1.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.3 |
2.1 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 |
1.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 |
1.6 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.3 |
0.8 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.3 |
1.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
1.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
1.0 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 |
0.8 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
1.0 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
1.2 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.2 |
1.7 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
0.5 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.2 |
1.5 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.2 |
1.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
1.0 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.2 |
0.5 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.2 |
1.9 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 0.2 |
0.5 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
1.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.7 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.2 |
1.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
1.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.7 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
0.9 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
1.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
6.8 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.2 |
0.5 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.2 |
0.7 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.2 |
0.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.2 |
0.7 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.2 |
1.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
0.7 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
0.9 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
3.4 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.2 |
2.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
0.9 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
1.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.2 |
0.9 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.2 |
0.7 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.2 |
0.9 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.2 |
2.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
1.1 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.2 |
0.6 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 |
1.1 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
0.9 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 |
1.1 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 |
0.6 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.2 |
0.4 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.8 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
1.7 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
0.6 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 |
1.9 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
3.3 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) |
| 0.2 |
1.7 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
1.4 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.2 |
0.6 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
1.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
1.6 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 |
0.8 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
2.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.2 |
0.4 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.2 |
0.6 |
GO:2000054 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.2 |
0.6 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
1.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
0.8 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 |
1.0 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
1.4 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
0.4 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.2 |
0.6 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 |
1.4 |
GO:0032308 |
positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 |
0.6 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 |
0.2 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.2 |
2.7 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
1.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
2.1 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.2 |
2.7 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
1.3 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
0.6 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
6.2 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 |
1.5 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.2 |
2.6 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
1.1 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.2 |
0.9 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
1.8 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.2 |
1.6 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
0.7 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.2 |
0.7 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.2 |
0.5 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.2 |
0.9 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
0.9 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.2 |
0.4 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.2 |
1.6 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.2 |
0.7 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.2 |
0.7 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.2 |
1.8 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.2 |
2.0 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.2 |
1.1 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.2 |
1.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 |
0.4 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.2 |
1.9 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
1.4 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.2 |
1.6 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.2 |
0.5 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.2 |
8.1 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.2 |
0.7 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 |
2.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.2 |
0.7 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
1.7 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.2 |
1.9 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.2 |
0.7 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
0.9 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
0.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.5 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.2 |
0.5 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.2 |
2.4 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.2 |
1.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
5.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
1.7 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.2 |
1.3 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.2 |
0.7 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.2 |
1.5 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
0.5 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.2 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.2 |
2.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
1.9 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
1.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.6 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.2 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.6 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 |
0.6 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.2 |
2.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
1.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.2 |
4.0 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.2 |
0.3 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.2 |
0.6 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.2 |
1.8 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
1.8 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
1.3 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.9 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
2.1 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.9 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
1.0 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
0.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
1.5 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
1.6 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
2.1 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.1 |
0.9 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
1.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.9 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.6 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.3 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.4 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
1.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.3 |
GO:1902913 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.1 |
2.9 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.8 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.6 |
GO:0016137 |
glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
| 0.1 |
0.3 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 |
0.4 |
GO:0034109 |
homotypic cell-cell adhesion(GO:0034109) |
| 0.1 |
0.4 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
1.5 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.5 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
8.0 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
1.0 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.5 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
2.4 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
1.9 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.1 |
GO:0032490 |
detection of molecule of bacterial origin(GO:0032490) |
| 0.1 |
3.2 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
0.7 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.7 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
1.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
1.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
1.2 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
0.9 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
2.1 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.1 |
1.3 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.3 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.6 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
1.0 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
2.2 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
0.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.6 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
5.6 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.7 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) fibrinolysis(GO:0042730) |
| 0.1 |
0.4 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.2 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.4 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.5 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.4 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.8 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
3.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.9 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.9 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.7 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 |
1.9 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.2 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
0.6 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
1.5 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.2 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.1 |
0.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
1.5 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
0.7 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.1 |
0.2 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.1 |
1.8 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 |
0.5 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
3.4 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 |
0.3 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.3 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.1 |
1.0 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
1.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.8 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.7 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.9 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.5 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.8 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.9 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.7 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.9 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.5 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.4 |
GO:0051790 |
short-chain fatty acid metabolic process(GO:0046459) short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.6 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.4 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.1 |
0.5 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.1 |
0.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.9 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.3 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
0.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.4 |
GO:0010756 |
regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
2.4 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
0.8 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.7 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.6 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
1.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.9 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.8 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 |
0.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.2 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.7 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
0.5 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.5 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.1 |
1.0 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.7 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.4 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
2.0 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
1.2 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.6 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
1.0 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.3 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 |
0.3 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
0.6 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.8 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.7 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.1 |
0.2 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
1.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
1.2 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 |
0.6 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.1 |
0.4 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.1 |
0.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.1 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.1 |
2.7 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.1 |
2.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
2.2 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.3 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.2 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.9 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
1.9 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
0.2 |
GO:0016068 |
regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
| 0.1 |
0.7 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
1.6 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.4 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.6 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
0.4 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.2 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.1 |
0.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
1.7 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.3 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 |
1.4 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.8 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.7 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.6 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 |
0.9 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.9 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
1.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
1.2 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 |
1.2 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
1.6 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.3 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.2 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.4 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.5 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.3 |
GO:0048643 |
positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.1 |
0.3 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
0.5 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
1.0 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.1 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.2 |
GO:0016064 |
immunoglobulin mediated immune response(GO:0016064) B cell mediated immunity(GO:0019724) |
| 0.1 |
0.3 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.7 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.2 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 |
0.2 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 |
0.4 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.3 |
GO:0051054 |
positive regulation of DNA metabolic process(GO:0051054) |
| 0.1 |
0.2 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.1 |
0.7 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.1 |
0.9 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.2 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.1 |
0.2 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.8 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.1 |
1.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.1 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.2 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.9 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.6 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.5 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 |
1.9 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
1.0 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
0.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.7 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
1.0 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.7 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
0.9 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.1 |
0.8 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
1.8 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.5 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.4 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.3 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.2 |
GO:0016056 |
phototransduction, visible light(GO:0007603) rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.5 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.1 |
2.0 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.8 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.4 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
2.9 |
GO:0032092 |
positive regulation of protein binding(GO:0032092) |
| 0.0 |
0.1 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.0 |
0.3 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.3 |
GO:0043173 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) nucleotide salvage(GO:0043173) |
| 0.0 |
0.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.5 |
GO:0048524 |
positive regulation of viral process(GO:0048524) |
| 0.0 |
1.7 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
1.7 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.0 |
0.0 |
GO:0009838 |
abscission(GO:0009838) |
| 0.0 |
0.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.8 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.7 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.0 |
1.7 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.6 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.2 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.0 |
3.8 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.2 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
2.4 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.2 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
1.3 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.2 |
GO:0015786 |
UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.0 |
1.0 |
GO:0006073 |
glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.0 |
0.3 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.4 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.1 |
GO:0050942 |
positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 |
1.4 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.2 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
1.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.0 |
0.1 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.1 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) |
| 0.0 |
0.1 |
GO:0035552 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0045852 |
lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
0.1 |
GO:0070236 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 |
0.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
1.2 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.8 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:0032753 |
positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 |
0.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.0 |
0.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.0 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.0 |
0.3 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.1 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.8 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.9 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.6 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.5 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.2 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.0 |
0.3 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.1 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.3 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.0 |
1.0 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.5 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.0 |
0.9 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.1 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.0 |
0.3 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.2 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.4 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
1.7 |
GO:0006457 |
protein folding(GO:0006457) |
| 0.0 |
0.1 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.0 |
0.6 |
GO:0000422 |
mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 |
0.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.3 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.1 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.0 |
2.1 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.7 |
GO:0061515 |
myeloid cell development(GO:0061515) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.5 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.8 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.3 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.0 |
0.4 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
1.3 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.0 |
0.0 |
GO:0031117 |
serotonin receptor signaling pathway(GO:0007210) positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.1 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.3 |
GO:0051145 |
smooth muscle cell differentiation(GO:0051145) |
| 0.0 |
0.4 |
GO:0090559 |
regulation of membrane permeability(GO:0090559) |
| 0.0 |
0.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.1 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.0 |
0.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.2 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.0 |
0.4 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.1 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.1 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
0.4 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.2 |
GO:0031641 |
regulation of myelination(GO:0031641) |
| 0.0 |
0.9 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.1 |
GO:0001916 |
regulation of T cell mediated cytotoxicity(GO:0001914) positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.0 |
0.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.2 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.4 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.0 |
0.8 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.7 |
GO:0000956 |
nuclear-transcribed mRNA catabolic process(GO:0000956) |
| 0.0 |
0.1 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.1 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.1 |
GO:0050818 |
regulation of coagulation(GO:0050818) |
